A unique intestinal epithelial cell that expresses canonical lymphoid genes
This study identifies a previously unrecognized, rare intestinal epithelial cell type called EDLCs that uniquely co-express canonical epithelial and lymphoid genes without rearranged receptors, exhibiting distinct epigenetic features and expanding in response to specific immune stimuli.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The lining of the human gut is a busy, living wall that separates the inside of the body from the outside world. It is made mostly of simple, column-shaped cells that absorb nutrients and secrete mucus to keep things moving smoothly. For a long time, scientists believed that the job of fighting infections in this specific layer belonged to a different group of cells entirely: the immune cells. These immune cells, specifically a type of white blood cell known as a lymphocyte, were thought to be the only ones capable of carrying out the sophisticated, targeted attacks associated with the body's adaptive immune system. They were the specialized soldiers, while the gut lining cells were just the bricks and mortar.
This division of labor seemed absolute. The soldiers carried specific identification tags and weapons that the bricks did not. However, the boundary between the wall and the army might not be as rigid as once thought. A new study challenges the idea that only immune cells can express the genetic programs needed for this kind of defense. By looking closely at the cells that make up the intestinal lining, researchers have discovered a rare, unexpected hybrid. These are cells that look and act like the gut's own bricks but carry the genetic instructions usually reserved for the immune soldiers. They are not invaders that have slipped inside; they are the wall itself, suddenly showing signs of a different kind of strength.
In a recent study published in a preprint, a team of scientists led by researchers at Dana-Farber Cancer Institute and other institutions identified a previously unknown type of cell in the intestines of mice and humans. They call these cells epithelium-derived lymphoid-like cells, or EDLCs. These are not the usual immune cells that patrol the gut. Instead, they are cells that originate from the gut lining itself. The researchers found that these cells are born from the same stem cells that create the standard absorptive and secretory cells of the intestine. Yet, as they mature, they begin to express a unique mix of genes. They keep the genes that make them part of the gut wall, but they also turn on a set of genes that are typically found only in T-cells, a major type of immune cell.
The discovery began when the researchers were studying the secretory lineage of the gut, the group of cells responsible for producing mucus and antimicrobial substances. Using genetic tools to track these cells, they noticed a small, strange group that did not fit the expected pattern. These cells were expressing genes for proteins like CD3 and CD8, which are classic markers for T-cells, as well as genes for granzymes, which are enzymes used by immune cells to kill infected or damaged cells. At the same time, these cells were still expressing the genes that define them as gut cells, such as those for keratin, a structural protein, and various secretory markers. They were a dual identity, wearing the uniform of the wall while holding the weapons of the army.
To be sure these were not just mistakes in their data, the team used several different methods to verify the finding. They looked at the cells under a microscope and found them to be large, column-shaped cells sitting in the lining of the gut, distinct from the small, round immune cells that usually squeeze between the gut cells. They used flow cytometry, a technique that sorts cells based on their surface markers, to isolate these rare cells and confirm they were indeed part of the gut lining and not a contaminant from the immune system. They even grew intestinal cells in a dish, away from any immune cells, and found that these hybrid cells still appeared, proving they did not need to fuse with an immune cell to acquire their new traits.
The researchers also checked the genetic material inside the nucleus of these cells. They found that the DNA in these cells was open and accessible in a way that allowed both gut-specific and immune-specific genes to be read. This epigenetic signature confirmed that the cells were not just accidentally holding onto immune RNA from a neighbor; their entire genetic machinery was set up to produce this unique combination of proteins. They lacked the genes for the specific receptors that T-cells use to recognize specific threats, which means they are not standard T-cells that have somehow ended up in the wrong place. They are a distinct, third type of cell.
These cells are rare in a healthy gut, making up less than one percent of the epithelial cells. However, their numbers change when the body faces certain challenges. When the researchers stimulated the mice with a signal that triggers a specific type of immune response known as a type 2 response, the number of these hybrid cells increased significantly. They also found more of them in mice with a specific genetic defect that causes chronic inflammation. In the lab, when they added a specific immune signaling molecule called interleukin-13 to the intestinal cells growing in a dish, the number of these cells doubled. This suggests that the gut lining has a built-in mechanism to produce these hybrid defenders when the body is under stress or fighting a specific kind of infection.
The study also looked at human tissue and found similar cells in the human small intestine. These human cells also carried the gut markers and the immune markers, sitting in the lining just like their mouse counterparts. This indicates that the phenomenon is not unique to mice but is likely a feature of the mammalian gut in general. The researchers noted that these cells are distinct from other known specialized gut cells, such as tuft cells, which also play a role in immunity but do not carry this specific mix of T-cell genes.
The presence of these cells suggests that the intestinal lining is more versatile than previously understood. While the gut wall has always been known to have some innate immune capabilities, the ability to produce cells that express the genetic program of a cytotoxic T-cell was a surprise. The researchers propose that these cells might act as a first line of defense, ready to eliminate infected or damaged cells right where the infection occurs, without waiting for the main immune army to arrive. They are not a replacement for the immune system, but rather an additional layer of protection that the gut can generate on its own.
The team was careful to rule out other explanations for their findings. They considered whether these cells might be the result of two different cells fusing together, a process that can happen in some biological contexts. However, the genetic and physical evidence argued strongly against this. The cells had single nuclei, not the double nuclei one would expect from a fusion event, and they lacked the specific genetic rearrangements that define true T-cells. They also ruled out the possibility that these were just dead cells or debris, as the cells were viable and functional. The evidence points to a genuine, distinct cell type that arises naturally from the gut's own stem cells.
This discovery adds a new chapter to our understanding of how the body protects itself. It shows that the barrier between the gut and the outside world is not just a passive wall but an active participant in the immune response. The gut lining can, under the right conditions, transform a small fraction of its own cells into defenders that carry the genetic tools of the immune system. While the exact function of these cells is still being explored, their existence suggests that the body has more ways to fight infection than we previously realized. The study does not claim to have solved the mystery of how these cells work or what their full impact is, but it firmly establishes that they exist and that they are a real, distinct part of the intestinal ecosystem.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.